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Polyclonal Diffusion of Beta-Lactamase-Producing
Enterococcus faecium
Mario Sarti,a Floriana Campanile,b Carla Sabia,c Maria Santagati,b Raffaele Gargiulo,a and Stefania Stefanib
Clinical Microbiology, S. Agostino-Estense Hospital, Baggiovara, Modena, Italya; Department of Bio-Medical Science, Section of Microbiology, Catania, Italyb; and
Department of Bio-Medical Science, University of Modena and Reggio-Emilia, Modena, Italyc
We describe here the isolation of 8 beta-lactamase-producing multidrug-resistant Enterococcus faecium isolates in 2010. All
strains showed diverse pulsed-field gel electrophoresis (PFGE) profiles, all belonging to the same clonal complex, CC17. By PCR
and hybridization experiments, the entire blaZ-blaI-blaR1 operon was found. The beta-lactamase activity was demonstrated at a
high inoculum and in the presence of methicillin after overnight incubation.
Since the first beta-lactamase-producing (Bla) Enterococcusfaecalis strainwas reported in 1981 byB.Murray (7), only a few
reports have appeared in the literature: the second E. faecalis strain
was isolated in 1983 (5), and since then, Bla E. faecalis strains
have been isolated from 11 cities in 4 countries, including clusters
and outbreak strains (8). In 1992, the first isolation of a Bla
Enterococcus faecium strain was described (3): since then, no evi-
dence of Bla enterococci has been reported (12).
In 2010, 8 strains of clinical isolates of E. faecium possessing 1-
to 3-fold less susceptibility to ampicillin plus sulbactam with re-
spect to ampicillin alone were studied for possible beta-lactamase
production. After rigorous laboratory tests, they were found to be
beta-lactamase producers. In this article, we report the prelimi-
nary characterization of these isolates, the presence of the genes
encoding the enzyme, and its hydrolytic activity detected in cell
debris and extracts of all strains.
(Part of this research was presented at the 51st Interscience
Conference on Antimicrobial Agents and Chemotherapy, Chi-
cago, IL, 17 to 20 September 2011.)
Eight strains of E. faecium were isolated from urine, blood, or
peritoneal fluid of patients at the Clinical Microbiology Labora-
tory of S. Agostino-Estense Hospital (Modena, Italy) during 2010
(Table 1). All isolates were identified and tested for antibiotic sus-
ceptibility by standard procedures using the Vitek2 system with
the GP and AST-GP586 cards (bioMérieux, Marcy l’Etoile,
France) and reconfirmed by the API Strept system (bioMérieux,
Marcy l’Etoile, France).
Strains were retested by a reference method (2) with broth
microdilution for the antibiotics penicillin, ampicillin, ampi-
cillin-sulbactam, erythromycin, clindamycin, tetracycline,
levofloxacin, vancomycin, and teicoplanin and were tested for
high-level resistance to aminoglycosides. All drugs, as standard
reference powders, were purchased from Sigma Chemical
Company, St. Louis, MO. E. faecalis ATCC 29212 was used as a
standard control.
Beta-lactamase activity was evaluated with and without induc-
tion with methicillin and ampicillin by using two assays: (i) the
nitrocefin disk test (Remel, Lenexa, KS) on whole cells and (ii) the
detection of the hydrolysis activity on enzyme preparations and
pellet (cellular debris), performed essentially following a protocol
previously published (16). Both assays were performed in dupli-
cate and reconfirmed. Staphylococcus aureus ATCC 29213 was
used as a Bla control strain.
Chromosomal extraction of whole genomic DNA was per-
formed as previously described (11). The sequence of the bla
operon blaZ-blaI-blaR1, carried on Tn552 by S. aureus (available
in GenBank, under accession no. X52734), was used to design the
primers by the VectorNTI program (Invitrogen). The bla operon
blaZ-blaI-blaR1 oligonucleotides used in this study and the corre-
sponding fragment sizes are provided in the supplemental mate-
rial. All strains were also screened for the presence of the following
resistance genes: erm(A), erm(B), and tet(M) (13); vanA, vanB,
vanC-1, and vanC-2/3 (10); and aph3, aac(6=)-Ie-aph(2)-Ia,
aph(2)-Ib, aph(2)-Ic, aph(2)-Id, aadA, and aadE (6). The 16S
rRNA gene was used as an internal control. The PCR amplifica-
tions for the target were performed in a Biometra personal cycler
(M-Medical srl, 2010; Comaredo, Milan, Italy).
Gene sequencing of the blaZ-blaI-blaR1 operon was carried
out on strain E030, and the vanB genes were sequenced for con-
firmation of the resistance determinants in four strains.
Pulsed-field gel electrophoresis (PFGE)macrorestriction anal-
ysis was performed with SmaI (New England BioLabs, Ipswich,
MA) following a modified protocol previously reported (1). Sim-
ilarities among macrorestriction patterns were identified accord-
ing to established criteria (15).
For the MLST scheme, PCR conditions and sequencing fol-
lowed the instructions given at http://efaecium.mlst.net/. The
presence of plasmids was investigated by using the Plasmid Midi
kit (Qiagen srl, Milan, Italy) according to the manufacturer’s in-
structions, preceded by one lysis step with 20 mg ml1 lysozyme
solution and incubation at 37°C for 30 min. The localization of
blaZwas determined by hybridization of I-CeuI-digested genomic
DNA with probes labeled with an enhanced chemiluminescence
kit (AmershamLife Science, GEHealthcare, United Kingdom) for
blaZ and 16S rRNA genes, as previously described (9).
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The 8 strains of Bla E. faecium were from documented infec-
tions, and all patients received the appropriate antibiotic therapy.
The strains were epidemiologically and genetically unrelated, be-
longing to 8 different PFGE profiles (Table 1). Sequence type (ST)
analysis showed the isolates were distributed in 6 different lin-
eages, all clustering in clonal complex 17 (CC17), the one inwhich
most of the hospital-derived isolates belong. In particular, ST117,
ST202, and ST78 are single-locus variants (slv) of ST17, while
ST192 and ST19 are double-locus variants (dlv), and ST18 is a
three-locus variant (tlv).
Table 2 shows the antibiotic susceptibilities of the 8 strains
together with their resistance gene contents. In all strains, theMIC
of ampicillin was also determined at a higher inoculum (107),
showing 2-fold-less-susceptible values; also, the MIC of ampicil-
lin/sulbactam was 1- to 3-fold less susceptible with respect to am-
picillin alone. All strains were phenotypically confirmed by the
nitrocefin test and genetically correlated with the presence—us-
ing PCR—of the entire bla operon constituted by the beta-
lactamase blaZ gene, the repressor blaI, and the antirepressor
blaR1. The internal sequences of the three genes showed the fol-
lowing nucleotide identities with Tn552 of S. aureus: blaZ, 97%;
blaR1, 96%; and blaI, 95%.
As regards the other antibiotic families, 6/8 strains possessed
high-level resistance (HLR) to both aminoglycosides due to the
presence of modifying enzymes: i.e., the aadE enzyme and the
bifunctional aac(6=)-Ie-aph(2)-Ia enzyme. Two of eight strains
were tetracycline resistant due to ribosomal protection [tet(M)
gene], and 4/8 were resistant to erythromycin due to the presence
of the erm(B) gene. One strain was resistant to vancomycin but
teicoplanin susceptible, due to the presence of the vanB2 gene, and
3 strains were vanB2-containing E. faecium, showing vancomycin
susceptibility, as already described (4, 14). The vanB2 genes were
sequenced in all strains and were identical, showing 99% nucleo-
tide identity to the vanB gene deposited inGenBank (accessionno.
AY9582201).
The beta-lactamase activity of our E. faecium strains was de-
tected in supernatants, with or without methicillin, only when a
high inoculum was used (108 CFU/ml); in all experiments, the
reaction was very slow and developed only a pale color at 24 h,
slightly recognizable with respect to the E. faecium ATCC 35667
negative control. In all strains tested, under these experimental
conditions, it was difficult to recognize a difference in intensity
between induced and uninduced cells.
The hydrolytic activity was also detected in crude extracts in
both the supernatants and the pellets containing cell debris and
membranes, after their growth under induced and uninduced
conditions with methicillin. Figure 1A shows the color difference
in the beta-lactamase activity in strain E030 used as an example of
the behavior of all of our strains. The nitrocefin reaction was de-
tected only in the pellet of E. faecium cells grown in the presence of
methicillin, rapidly developing a red color in 24 h (vial 4c), while
all other vials remained negative, as did the negative control
TABLE 1 Isolates of E. faecium and their PFGE profiles and STs
Strain
Date of isolation
(mo/yr)
MIC (mg/liter) ofa:
Clinical specimen PFGE pattern STAMP SAM
E030 2/2010 8 2 Urine B 117
C236 8/2010 16 4 Urine A 18
E032 2/2010 16 4 Urine C 117
E031 3/2010 8 2 Urine D 202
E029 3/2010 16 8 Urine E 19
F13 6/2010 32 16 Peritoneal fluid F 192
F14 6/2010 32 16 Blood G 117
G90 11/2010 32 32 Blood H 78
a AMP, ampicillin; SAM, ampicillin-sulbactam.
TABLE 2 Antibiotic resistance of strains and correlation with antibiotic resistance gene content
Strain
MIC (mg/liter) ofa: HLARb
Resistance gene contentAMP SAM ERY CLI TET LVX TEC VAN GEN STR
E030 8 2 1 0.25 16 4 0.5 1 No No blaZ-blaI-blaR1 tet(M)
C236 16 4 8 8 16 8 0.5 0.5 Yes Yes blaZ-blaI-blaR1 erm(B) tet(M) aadE aphA3
aph(2)-1b
E032 16 4 4 0.25 2 8 4 1 No No blaZ-blaI-blaR1
E031 8 2 0.25 0.25 2 8 0.5 1 Yes Yes blaZ-blaI-blaR1 aadE aphA3 aph(2)-1b vanB2
E029 16 8 8 8 1 8 0.5 1 Yes Yes blaZ-blaI-blaR1 erm(B) aadE aphA3
aph(2)-1b
F13 32 16 8 8 1 8 0.5 0.5 Yes Yes blaZ-blaI-blaR1 erm(B) aadE aphA3 aph(2)-
1b vanB2
F14 32 16 8 8 1 8 0.5 0.5 Yes Yes blaZ-blaI-blaR1 erm(B) aadE aphA3 aph(2)-
1b vanB2
G90 32 32 8 8 1 8 2 8 Yes Yes blaZ-blaI-blaR1 erm(B) aadE aphA3 aph(2)-
1b vanB2
a AMP, ampicillin; SAM, ampicillin-sulbactam; ERY, erythromycin; CLI, clindamycin; TET, tetracycline; LVX, levofloxacin; TEC, teicoplanin; VAN, vancomycin.
b HLAR, high-level aminoglycoside resistance.
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(vial 1b). On the contrary, both S. aureus vials (free extract and
pellets with and without methicillin) rapidly developed a more
intense red color demonstrating abundant enzyme release (vial
1a). Figure 1B shows the time of the color development in
pellets and extracts. The enzymatic activity was better detected
in pellets with respect to cell extracts, in the presence of meth-
icillin, and at 24 h.
Six out of the 8 Bla E.faecium strains harbored plasmids of
small sizes ranging from 2 to 5 kb (Table 1). To define the local-
ization of the blaZ gene cluster, hybridization experiments, using
total DNAdigestedwith I-CeuI, were performed in all strains. The
bla operon was assigned to the chromosome after successive hy-
bridizations with 16S rRNA and blaZ probes (see the supplemen-
tal material).
The Bla E. faecium isolates in our study remained generally
ampicillin resistant even in the presence of a beta-lactamase inhib-
itor, demonstrating they are also intrinsically resistant to beta-
lactams: in only two strains, possessing low-level resistance to am-
picillin, was the addition of sulbactam able to restore a full
susceptibility profile. Different characteristics seem to be impor-
tant to explain the beta-lactamases activity demonstrated by the E.
faecium isolates in this study. (i) Our strains possessed the entire
blaZ-blaI-blaR1 operon located on the chromosome, and the
three genes are highly homologous to those of S. aureus origin. (ii)
Contrary towhat has been published to date on E. faecium (3), our
activity was better detected when strains were grown in the pres-
ence of methicillin. (iii) Nitrocefin hydrolysis was detected better
in pellets with than in cell extracts (3, 8).
Further studies are in progress to address the many unan-
swered questions, regarding the functionality of this beta-
lactamase in E. faecium, the sequence of the entire element, and its
possible transferability. It is not clear if Bla enterococci are fre-
quent in clinical settings, and the impact of this hydrolytic mech-
anism on the complex picture of ampicillin resistance in this spe-
cies is less clear.
(While we were writing this article, other Bla isolates, both E.
faecalis and E. faecium, were isolated.)
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